CONMED (CNMD) PT Lowered to $40 at JPMorgan
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $49.85 -0.26%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
JPMorgan analyst Robbie Marcus lowered the price target on CONMED (NYSE: CNMD) to $40.00 (from $43.00) while maintaining a Neutral rating.
You May Also Be Interested In
- RBC Capital Downgrades Bapcor Ltd. (BAP:AU) to Underperform
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $109 at Raymond James
- Assembly Biosciences (ASMB) PT Lowered to $45 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
